Filter
244
Text search:
medicine
manufacturing
Featured
Recommendations
21
New Publications
48
Language
Document type
No document type
100
Studies & Reports
60
Guidelines
47
Manuals
14
Strategic & Response Plan
13
Fact sheets
4
Training Material
2
Situation Updates
2
Brochures
1
Resource Platforms
1
Countries / Regions
Kenya
12
Ghana
11
Global
8
India
7
Ethiopia
6
Zimbabwe
6
Uganda
5
Tanzania
5
Western and Central Europe
5
Nepal
4
South–East Asia Region
4
Sierra Leone
3
Philippines
3
Zambia
3
Syria
3
South Africa
3
Malawi
3
Nigeria
2
Senegal
2
Congo, Democratic Republic of
2
USA
2
Cameroon
2
Sudan
2
Botswana
2
Eastern Europe
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Pakistan
1
South Sudan
1
Germany
1
Chad
1
Cambodia
1
Rwanda
1
Benin
1
Namibia
1
Ukraine
1
Angola
1
Lesotho
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Africa
1
Tajikistan
1
Moldova
1
Turkmenistan
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
88
Clinical Guidelines
15
Public Health
14
Pharmacy & Technologies
11
Key Resources
8
Women & Child Health
3
Capacity Building
2
Toolboxes
AMR
28
COVID-19
26
Pharmacy
24
HIV
16
Planetary Health
16
TB
14
Disability
5
Mental Health
5
Specific Hazards
5
Malaria
5
Conflict
4
Global Health Education
4
NTDs
4
NCDs
4
Natural Hazards
3
Rapid Response
3
Refugee
3
Ebola & Marburg
2
Caregiver
2
2.0 Rapid Response
2
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the
...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing
...
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi
...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi
...
Impact of EU policies on accessing protection. The report highlights the tragedy hundreds of thousands of people face when seeking protection in Europe. Women, men and children escaping war, repression and violation of human rights often turn to Europe in the hope of finding a safe haven. But many a
...
Extraced from the full version of WDI 2016
The Faster We Go, the Health We'll Be.
The report outlines five climate solutions that research shows will deliver immediate, often localized, health and equity benefits. Our focus is on the solutions that proactively advance both health and health equity, recognizing that some of us face greater h
...
Indian markets caused a stir across the country.1
According to the Centre for Science and the Environment (CSE), a respected New Delhi-based NGO, most honey brands
sold in India contained varying amounts of antibiotics. Their consumption over time could induce resistance to antibiotics,
putting p
...
New funding requirements: CHF 2.8 billion IFRC-wide of which CHF 670 million is channelled through the IFRC Emergency Appeal in support of National Societies
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug
...
Revised Edition
